Two of Intouch's innovation experts attended CES 2020 earlier this month and brought back highlights from the conference, including scary-real-looking, AI-powered artificial humans, advances in personal health tech and more.
Two of Intouch's own -- group creative director Charley Aldridge and senior VP, medical director David Mustalish, MD -- recently spoke with the folks at PharmaVOICE about the value of storytelling in pharma marketing.
The Instagram interface – a photo, below which appears a number of likes – is so well-known, it was its own Halloween costume. That’s changing, though, as parent company Facebook Inc. attempts to counter criticism that the social network engenders constant comparison. How will pharma marketers be affected?
Download the POV Executive Summary Corporate data security is big business. Unfortunately, cybercrime is much, much bigger business. Cybercrime is estimated to cause the world $6 trillion in annual damages by 2021 — the largest transfer of wealth in the history of the world, forty times more than the
If you, too, had a busy year and perhaps missed some of what we talked about, here's a look back at Intouch's 10 most-read posts of 2019 -- read on to get caught up and ready for 2020!
Backlinks are like online “street cred”; they can boost a site’s authority and help move it up the ranks of a search engine results page. Pharma brands that neglect implementing a link-building strategy are missing opportunities their competitors may not.
Modern content marketing is effective, costing 62% less than traditional marketing, and drives approximately three times as many leads. But how do you avoid repetitive efforts, ensure expired or outdated materials are retired from the public eye & create cohesive cross-channel communications? Learn more here.
In this piece for the Forbes Tech Council, Intouch EVP David Windhausen addresses three common fears about data security and why those fears are unfounded.
In this POV, we explain what’s most important for you to know, recommend ways that you can stay ahead of the curve, and provide links to additional reading.
In the world of pharma, spillover refers to instances in which healthcare providers (HCPs) alter their prescribing behavior in response to -- sometimes inaccurate -- perceptions of restricted access, or perhaps in response to patient complaints about co-pay burden or drug pricing. Learn about what's needed to predict spillover and avoid the problems that come with it.